These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14737743)

  • 1. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy.
    Curtis TM; Scholfield CN
    Diabetes Metab Res Rev; 2004; 20(1):28-43. PubMed ID: 14737743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKC inhibition and diabetic microvascular complications.
    Clarke M; Dodson PM
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):573-86. PubMed ID: 18054736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of protein kinase C in the pathophysiology of diabetic retinopathy].
    Lang GE; Kampmeier J
    Klin Monbl Augenheilkd; 2002 Nov; 219(11):769-76. PubMed ID: 12494366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of diabetic retinopathy.
    Lang GE
    Ophthalmologica; 2007; 221(2):112-7. PubMed ID: 17380065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis.
    Gardiner TA; Archer DB; Curtis TM; Stitt AW
    Microcirculation; 2007 Jan; 14(1):25-38. PubMed ID: 17365659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinases as glucose transducers for diabetic complications.
    Tomlinson DR
    Diabetologia; 1999 Nov; 42(11):1271-81. PubMed ID: 10550410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy: current management and experimental therapeutic targets.
    Ali TK; El-Remessy AB
    Pharmacotherapy; 2009 Feb; 29(2):182-92. PubMed ID: 19170588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein kinase C might be harmful to diabetic retinopathy.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2004; 63(1):135-7. PubMed ID: 15193366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current views on the development of diabetic retinopathy].
    Sosna T
    Cas Lek Cesk; 2002 Nov; 141(22):697-701. PubMed ID: 12532906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evalution of oxidative stress in diabetic animals by in vivo electron spin resonance measurement--role of protein kinase C.
    Sonta T; Inoguchi T; Tsubouchi H; Sekiguchi N; Kobayashi K; Matsumoto S; Utsumi H; Nawata H
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S109-13. PubMed ID: 15563958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.
    Budhiraja S; Singh J
    Fundam Clin Pharmacol; 2008 Jun; 22(3):231-40. PubMed ID: 18485142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incipient diabetic retinopathy--insights from an experimental model.
    Feng Y; vom Hagen F; Lin J; Hammes HP
    Ophthalmologica; 2007; 221(4):269-74. PubMed ID: 17579294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.
    Joy SV; Scates AC; Bearelly S; Dar M; Taulien CA; Goebel JA; Cooney MJ
    Ann Pharmacother; 2005 Oct; 39(10):1693-9. PubMed ID: 16160002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific medical intervention for diabetic retinopathy.
    Ng JS
    Med Hypotheses; 2009 Aug; 73(2):158-60. PubMed ID: 19380207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
    Pan HZ; Zhang H; Chang D; Li H; Sui H
    Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal blood flow in diabetes.
    Clermont AC; Bursell SE
    Microcirculation; 2007 Jan; 14(1):49-61. PubMed ID: 17365661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.